Yearly Archives: 2026

The Department of Health and Social Care (DHSC) has today (25/09/2026) confirmed the following list of price concessions for September 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]

The post September 2026 Price Concessions 6th Update appeared first on Community Pharmacy England.

Community Pharmacy England has made changes to its constitution and rules to enable the formation of a rebalanced Committee from April 2027. In the latest step on a journey to better reflect the make-up of the sector, the constitutional adjustments implement the decision made in June 2026 to make a series of interim composition changes [...]

The post Constitution changes pave way for 2027 pharmacy elections appeared first on Community Pharmacy England.

Today, 25th September, we’re celebrating World Pharmacists Day – an annual event led by the International Pharmaceutical Federation (FIP) that recognises the expertise, dedication and vital contribution of pharmacists and pharmacy teams in supporting patients and communities every day. This year’s theme, ‘Empowering pharmacists for healthier futures’, highlights the growing contribution of pharmacists to patient [...]

The post World Pharmacists Day 2026: Empowering pharmacists for healthier futures  appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has today (24/09/2026) confirmed the following list of price concessions for September 2026: Please note: Community Pharmacy England has submitted price concession applications for a number of other medicines affected by pricing issues this month. We will issue further updates as soon as we hear back from the [...]

The post September 2026 Price Concessions 5th Update appeared first on Community Pharmacy England.

MHRA Class 4 Medicines Defect Notification: Meropenem 1000 mg powder and solvent for solution for infusion (B. Braun Melsungen AG) Drug alert number: EL(26)A/39 Date issued: 23 September 2026 B. Braun Melsungen AG has notified the MHRA that errors have been identified in the Patient Information Leaflet (PIL) included in some batches of Meropenem 1000 mg [...]

The post MHRA Class 4 Medicines Defect Notification: Meropenem 1000 mg powder and solvent for solution for infusion (B. Braun Melsungen AG) appeared first on Community Pharmacy England.